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It is believed that immunoglobulin-variable region gene (IgV) somatic hypermutation (SHM) 
is initiated by activation-induced cytidine deaminase (AID) upon deamination of cytidine to 
deoxyuracil. Patch-excision repair of these lesions involving error prone DNA polymerases 
such as pol
 
 
 
 causes mutations at all base positions. If not repaired, the deaminated 
nucleotides on the coding and noncoding strands result in C-to-T and G-to-A exchanges, 
respectively. Herein it is reported that IgV gene evolution has been considerably influenced 
by the need to accommodate extensive C deaminations and the resulting accumulation of 
C-to-T and G-to-A exchanges. Although seemingly counterintuitive, the precise placement 
of C and G nucleotides causes most C-to-T and G-to-A mutations to be silent or conservative. 
We hypothesize that without intricate positioning of C and G nucleotides the efficiency of 
affinity maturation would be significantly reduced due to a dominance of replacements 
caused by C and G transition mutations. The complexity of these evolved biases in codon use 
are compounded by the precise concomitant hotspot/coldspot targeting of AID activity and 
Pol
 
 
 
 errors to maximize SHM in the CDRs and minimize mutations in the FWRs.
 
Individual B cells activated by antigen binding
and T cell help will undergo a rapid prolifera-
tion to form many identical clones. During
this process the Ig of each antigen-reactive
clone is altered by somatic hypermutation
(SHM; 1), which causes a million-fold increase
in the frequency of point mutations of the Ig-
variable region genes (2) and rare insertions
and deletions (3). Current paradigms teach that
individual clones then compete for antigen in
a Darwinian fashion, resulting in the clonal se-
lection of B cells harboring receptors of the
highest specificity and affinity for the antigen.
Recent progress has demonstrated that the
molecular processes of both SHM and immu-
noglobulin class switch recombination (CSR)
require the activity of activation-induced cyti-
dine deaminase (AID; 4, 5).
AID is a cytidine deaminase but there is
controversy as to if its substrate in vivo is a
specific mRNA (RNA editing model) or if
AID acts directly on the DNA (DNA deami-
nase model). According to the RNA-editing
model, AID will deaminate a C to form a U
on an unknown mRNA molecule that will re-
sult in the change of a codon and expression of
a new amino acid sequence. This change in
the peptide sequence will result in an activated
protein that mediates SHM and CSR. This
model was conceived because the protein most
homologous to AID is APOBEC-1 that has an
RNA-editing function (6). However, most in-
vestigators work under the assumption that
AID directly deaminates Cs of immunoglobu-
lin variable region (IgV) gene DNA or class
switch regions to initiate SHM or CSR (7).
The deamination of C to U on the coding
strand would result in a U/G base mismatch
(phase I of SHM; 8). Phase II of SHM involves
various DNA repair processes. Pairing of the
U with an adenosine during DNA replication
would result in one of the daughter cell lin-
eages having a C-to-T transition mutation.
Similarly, deamination of noncoding strand Cs
would result in G-to-A transitions if not re-
paired. Alternatively, the U/G mismatch can
be repaired by various mechanisms including
short-patch excision repair with error-prone
polymerases that would introduce additional
mutations at all base positions in the surround-
ing sequence. There is now ample evidence
that the error-prone DNA polymerases 
 
  
 
(9–13),
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(14, 15), and possibly 
 
  
 
(16,17) have a direct role in SHM
(for review see reference 18). Evidence that AID directly
deaminates DNA has been presented in a number of recent
reports (7, 19–27), and AID has now been shown to associ-
ate with a synthetic DNA substrate of SHM in conjunction
with replication protein A
 
 
 
(28). Direct evidence for the en-
tire model of SHM involving initiation by DNA deamina-
tion and then various pathways of error-prone repair was re-
cently reported by Rada and colleagues
 
 
 
(29). In this report
CSR was ablated and SHM was limited only to mutations
that would result from C deamination (C-to-T and G-to-A)
in mice deficient for both uracil nucleotide glycosylase and
the mismatch repair factor MSH2. In fact, although C and G
mutations in these mice were all transitions, these mutations
still occurred frequently, suggesting that many C and G mu-
tations occur due to the direct activity of AID.
Immunoglobulin SHM is transcription dependent
 
 
 
(30),
displays nucleotide exchange bias for transitions and se-
quence motifs referred to as hotspots accumulate mutations
at increased frequencies and coldspots at reduced frequencies
(31–34). Hotspots of somatic mutation have classically been
defined as “RGYW” motifs representing the nucleotide se-
quence AG/G/CT/AT with targeting of the underlined G,
or its reverse complement (WRCY or AT/GA/C/GA).
The hotspot motif has now been further refined to the motif
DGYW (AGT/G/CT/AT) and complement WRCH (AT/
GA/C/TAC; 35). This hotspot motif likely represents the
composite of AID preferred sites for deamination and the
most error prone sites of the polymerases involved in SHM.
Through in vitro analyses of AID activity it is now known
that a large part of mutational hotspot/coldspot targeting is
likely due to the preferred (hotspot) nucleotide substrate of
AID, which is the C nucleotide of WRC (AT/AG/C) mo-
tifs, and the repression (coldspot) of AID activity at SYC
(GC/CT/C) or the third Cs in the trinucleotides: TTC,
CAC, GGC and GAC (23,27). The reverse complement of
these hotspots and coldspots modulate AID activity on the
noncoding strand. In addition, it is known that Pol
 
 
 
 is criti-
cal for AT mutations during SHM and is particularly error
prone for coding strand adenosines preceded by A or T
(WA) that are preferentially mutated to G (9–13, 18). Loss of
surface Ig leads to B cell death (36), thus replacement muta-
tions of structurally important amino acids and nonsense
mutations will be avoided. Independent of these selective in-
fluences, it is evident that the antibody V gene sequences
have evolved targeting with mutational hotspots to maxi-
mize mutations of the diverse CDRs while minimizing mu-
tations to the structurally important FWRs (33, 37, 38).
With recent progress in understanding the molecular
mechanism of SHM and the role of AID and C deamina-
tion, it is important to better define the role of the V genes
themselves in directing this process. In recent years our labo-
ratory has sequenced many somatically mutated human IgV
heavy chain genes (IgVH). For this study, a total of 28,307
somatic mutations were analyzed for nucleotide exchange
frequency, codon bias, AID hotspot and coldspot targeting,
and silent versus replacement mutation tendencies. In addi-
tion, the entire set of human IgVH genes was similarly char-
acterized for mutational targeting. From these analyses we
conclude that targeting of SHM through evolution of the
IgV gene sequences goes well beyond preferential position-
ing of hotspot motifs in the CDRs.
Evidence is presented that IgVH genes have evolved to
support the initiation of SHM by AID, but to minimize the
occurrence of C-to-T–induced amino acid replacements
through intricate positioning of coding strand Cs. Targeting
of AID is also present but not as dramatic for the noncoding
strand as evident by placement of guanosines such that as for
C-to-T exchanges, mutations to A (noncoding strand dC-
to-dU deaminations) result in predominantly silent muta-
tions in the FWRs, and the G-to-A exchange is biased to
produce conservative amino acid replacements in the CDRs.
C and G transitions are also targeted to the CDRs and avoided
in the FWRs by positioning in AID hotpots and coldspots.
The result is a normalization of the frequency of amino acid
replacements that arise during patch excision–repair of the nu-
cleotides proximal to the AID-induced dU/G mismatches.
The evolution of the IgV genes to support C-to-T and G-to-A
transition mutations provides compelling evidence that AID
acts as a direct DNA C deaminase. Finally, juxtaposed on the
precise placement of Cs and Gs is preferential placement of As
and Ts in hotspots of Pol
 
 
 
 mutation in the CDRs and exclu-
sion from these sites in the FWRs. Thus, targeting of amino
acid replacement mutations to the CDRs rather than the
FWRs, which has traditionally been attributed to selective
processes, is also directed by the codons used to encode V
gene sequences. This analysis demonstrates that evolution of
the V genes as a substrate of the SHM process is significantly
more intricate than previously appreciated. A model is pre-
sented where in the absence of this targeting the efficiency of
affinity maturation would be greatly reduced.
 
RESULTS
Analysis of somatically mutated variable region 
gene sequences
 
B cells from various populations that harbor somatic muta-
tions (germinal center, memory, plasma cells, and the C
 
 
 
class-switched B cells C
 
 
 
-CS or IgD-only B cells) were iso-
lated from the tonsils and blood of 27 donors by flow cy-
tometry and were used to clone and sequence 1,919 IgVH
gene cDNAs. Many (662) of the sequences were generated
from B cells of the extensively mutated C
 
 
 
-CS lineage (39,
40) thus providing a large data set of mutations for analysis.
A total of 28,307 somatic mutations in 555,729 IgVH gene
nucleotides sequenced were analyzed for nucleotide ex-
change frequency, codon bias, hotspot and coldspot target-
ing, and silent versus replacement mutation tendencies. Ta-
ble S1 (available at http://www.jem.org/cgi/content/full/
jem.20042483/DC1) provides a list of all mutations analyzed
in addition to NCBI accession numbers for the reference V 
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genes, and indicates the B cell populations from which each
V gene was sequenced. Clonal sequences (derived from the
same founder), which are common in certain B cell popula-
tions, were scored both for unique mutations occurring for
each clone only and with all mutations included. The results
were virtually identical and thus all mutations that occurred
are included in Table S1. Background mutations due to
PCR or reverse transcription errors were determined to oc-
cur at a frequency of 0.0025 (0.25%) based on analyses of a
portion of the Ig constant region sequenced with many of
the IgVH gene sequences. Thus, 71 of the 28,307 mutations
reported may have been due to experimental error, which is
well below a threshold that could confound these analyses.
In addition, VH gene sequences were compared with the V
gene sequence set from the Immunogenetics database (41)
 
 
 
as
this set includes most known V gene polymorphic variants,
and thus nucleotides differing from the germline genes due
to polymorphisms would not be identified as mutations. In
certain instances nucleotides altered for all instances of a V
gene sequenced from a particular donor were considered to
be previously unreported polymorphisms, and thus were not
counted as mutations in the analyses herein. Estimation of
the frequency of mutations that occurred as secondary muta-
tions (for instance C-to-T-to-A) by analysis of clonally re-
lated sequences demonstrated that these mutations were un-
substantial to the whole and so were not accounted for.
 
Somatically mutated human IgV
 
H
 
 genes accumulate C-to-T 
base exchanges that are predominantly silent
 
As illustrated in Fig. 1 A, of the 28,307 mutations analyzed
G-to-A (4,730, 17%) and C-to-T (4,098, 14%) base ex-
changes were the most common. Either of these mutations
could have occurred through fixation of the AID-targeted
deamination of deoxycytidine to deoxyuracil. The C-to-T
exchanges would result if Cs were deaminated on the coding
strand and G-to-A exchanges would result from C deamina-
tion on the template strand. As shown in Fig. 1 B, most C
mutations occurred at AID hotspot motifs. Similarly, prefer-
ential targeting of Cs within reverse complement hotspots
(resulting in G mutations) is indicative of AID activity on
the noncoding strand (Fig. 1 B). Based both on the predom-
inant hotspot targeting and on previous analyses attributing
many C and G transitions to AID activity (Introduction), the
high frequency of C and G mutations are likely due to AID-
induced C deaminations that are not repaired or are improp-
erly repaired. There is also a clear preference for A-to-G and
Figure 1. SHM is biased for the introduction of excessive silent 
C-to-T and G-to-A exchanges. (A) The silent (white areas of bars) and 
replacement (black areas of bars) base exchange tendencies of 28,307 so-
matic mutations from 1,919 human IgVH genes. (B) Distribution of C-to-T 
and G-to-A silent (gray) and replacement (black) mutations to hotspots, 
coldspots, and neutral positions (x-axis), and the proportion of the various 
exchanges in AID hotspots or coldspots (y-axis) compared with A and T 
exchanges. AID hotspots and coldspot definitions are within the text 
(see introduction). (C) Analysis of the genetic code and non-IgV genes. 
Predicted occurrence of silent (white), replacement (black), or nonsense 
(gray) mutations for the 12 nucleotide exchanges. This analysis represents 
the sum result if every nucleotide was mutated to each of the three other 
nucleotides, and thus the sum of all possible mutations that could occur 
based on codon composition. The non-IgVH genes analyzed are listed 
within the text. CS, cold spot; HS, hot spot; Rep., replacement. 
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less for T-to-C transitions (Fig. 1 A), corresponding with
many previous analyses demonstrating overall increased tran-
sitions by SHM, and consistent with the mutation spectrum
introduced by Pol
 
 
 
 that is critical for SHM, particularly at
AT nucleotides (9–13, 18). As previously described transver-
sion mutations were generally reduced, however G-to-C
transversions were unexpectedly common. It is notable that
70% of these atypical G-to-C transversions were silent or
caused highly conservative S-to-T or V-to-L amino acid ex-
changes at particular positions in CDR1 and FWR3 (see Fig.
2, many at positions 35 and 83), suggesting a role for selec-
tion in the accumulation of these mutations.
Strikingly, as shown in Figs. 1 A, the C-to-T mutations
that occurred were 77% (3,157/4,098) silent compared with
the expected frequency based on the genetic code or analysis
of non-IgV genes (42 and 48%, respectively) if all codons
were used equivalently (
 
 
 
2
 
, P 
 
  
 
0.0001; Fig. 1 C). Overall,
despite 12 possible exchanges, one third of all silent muta-
tions (3,157/9,394 or 34%) and eleven percent of all muta-
tions (both silent and replacement) were silent C-to-T tran-
sitions. This is nearly threefold greater than the expected
frequency of 3.8% for silent C-to-T mutations based on the
genetic code or analysis of non-IgV genes (Fig. 1 C, 
 
 
 
2
 
, P
 
 
 
0.001). Thus the ratio of replacement (R) to silent (S) mu-
tations for C-to-T exchanges (1/3 R to S) was opposite to
that of all mutations that occurred as 3/1 R to S (9,394 silent
in 28,307 total mutations, or 33%). It is notable that G-to-A
exchanges (noncoding strand C-to-T) were also skewed to
cause an increased frequency of silent mutations relative to
that predicted by the genetic code, but not as dramatically as
the skewing of C-to-T mutations (Fig. 1, A and B). In con-
clusion, C-to-T exchanges occurred as predominantly silent
mutations, suggesting that the IgV genes have evolved to
avoid replacements due to the initiating AID-mediated
deamination of Cs.
 
C-to-T transitions in the CDRs are predominantly silent, 
whereas all other exchanges in the CDRs are 
predominantly replacements
 
Regional accumulation of mutations is a hallmark SHM of
functional antibody genes. This tendency is believed to be
due in large part to selection against mutations in the struc-
turally important FWRs, which would be predicted to dis-
rupt the structure of the Ig, causing the BCR-deficient cells
Figure 2. A high frequency of silent C-to-T exchanges in the CDRs 
corresponds to mostly replacement mutations by all other exchanges. 
The distribution of silent (white portion of bars) and replacement (black 
portion of bars) mutations. Asterisks indicate amino acid positions where 
most of the C-to-T exchanges occurred at AID hotspot motifs (WRC). 
Whereas C-to-T exchanges are nearly all silent, G-to-A exchanges are 
predominantly silent in the FWRs only. 
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to die (36). Both silent and replacement mutations accumu-
lated in the CDRs whereas mutations that occur in the
FWRs are preferentially silent (Fig. 2). However, unlike
other exchanges that are predominantly replacement muta-
tions in the CDRs, C-to-T exchanges in the CDRs are
nearly all silent (Fig. 2, white portions of bars). In addition,
most silent C-to-T mutations in the FWRs are found within
the last several codons proximal to the CDRs (Fig. 2, codons
27–30 of FWR1, codon 51 of FWR2, codons 94–96 of
FWR3) or within the hypervariable portion of FW3 be-
tween codons 76–85. The accumulation of mutations and
apparent AID targeting at residues 76–85 of FWR3 is not
surprising as this region is known to be highly variable and
mutable in humans and has been demonstrated to contribute
to the antigen combining surface for certain antigens, and
therefore has even been suggested by some to be “CDR4”
(42). Strikingly, coincident with the bias for silent C-to-T
exchanges in the CDRs is a significant bias for replacements
caused by all other exchanges. Bias for silent mutations in the
FWRs is likely due to selection against B cells with loss of
function mutations in the FWRs. However, the silent muta-
tion frequency for G-to-A exchanges (indicative of AID-
induced C deaminations on the noncoding strand) is particu-
larly high, suggesting more than just selection. Indeed, as
described below, Gs are preferentially placed in the FWRs
so that mutation to A is more likely to be silent. In conclu-
sion, although the SHM mechanism may be initiated by fre-
quent AID-induced deaminations of C nucleotides, amino
acid replacements due to C deamination are avoided in the
CDR and FWRs of the coding strand and in the FWRs of
the noncoding strand. Although a portion of these mutations
may have resulted from selection against replacement muta-
tions overall, the analyses presented below demonstrate that
in fact targeting of AID activity by the V gene sequences
themselves have precisely evolved to direct much of these
mutational biases.
 
The genetic code favors silent C-to-T exchanges
 
Targeting of the SHM process such that most C-to-T muta-
tions are silent may be intrinsic to the genetic code or to
normal biases in codons used to encode most genes. To ad-
dress this possibility, the results of all possible mutations to
the 61 codons that encode amino acids (excluding the three
stop codons) were scored. Thus, each nucleotide of each
codon was scored for the result of exchanges to the other
three nucleotides and the frequency that each of the 12 ex-
changes could cause silent or replacement mutations were
tallied (Fig. 1 C). Of the 48 Cs used in various codons of the
genetic code, C-to-T exchanges at 20 of these Cs will result
in silent mutations. Thus if all codons are used equivalently
to encode peptides, 56% of Cs if mutated to thymidine
would cause amino acid substitutions, 2% nonsense or stop
codons, and 42% would cause silent mutations (Fig. 1 C).
This is despite a ratio of 
 
 
 
3/1 for replacement versus silent
mutations for all other exchanges (24.8% silent, 71.6%
amino acid replacement, and 3.6% nonsense mutations). If
all codons are used stochastically to encode genes then this
bias in the genetic code for silent mutations following C-to-T
exchange should be reflected in all genes. To address this
possibility, 17 genes that were not IgVH genes were ran-
domly chosen and it was similarly determined what the sum
result of all possible exchanges would be (Fig. 1 C). Surpris-
ingly the codons used by these genes have an even greater
tendency of C-to-T mutations to be silent than that pre-
dicted by the genetic code in that a 1/1 ratio of silent to re-
placement mutations following C-to-T exchange is ex-
pected (3,092 of 6,227 Cs). This analysis was based on the
compiled codons used by the following genes: RNase A,
myoglobin, 
 
 
 
-actin, MAP4 kinase, p53, NF
 
 
 
B, cyclin D2,
Raf, GAPDH, collagen, DNA polymerase 
 
 
 
, CD40 ligand
(CD154), Fas ligand, CD38, the immunoglobulin Fc
 
 
 
 re-
ceptor 1, IgG constant region, and AID itself. In conclusion,
the genetic code is biased so that C-to-T mutations are more
frequently silent relative to all other base exchanges. Thus
the SHM mechanism may have evolved to use AID, which
is a C-deaminating enzyme (a C-to-T mutator) to generate
the initiating lesion in order to allow mutational targeting,
but with a minimum of amino acid replacements. However,
bias in the genetic code for C-to-T transitions to be silent
accounts for only a portion of the 77% of C-to-T exchanges
observed from SHM that are silent, and provides no insight
as to why G-to-A exchanges would be preferentially silent.
 
Biases in codon usage target C-to-T and G-to-A exchanges
 
Natural selection may have evolved the IgVH genes to have a
biased distribution of C nucleotides so that when mutated to
thymidine, silent mutations preferentially result. To address
this possibility the V genes themselves were analyzed to de-
termine what mutations could occur. The entire set of IgVH
molecules in this study was separated into individual codons
to determine if indeed V genes have a biased distribution of
C and G nucleotides (unmutated, germline counterparts of
the IgVH genes were analyzed). Tables S2 through S6
present the counts and analyses of each codon used by vari-
able gene region (available at http://www.jem.org/cgi/con-
tent/full/jem.20042483/DC1). The entire data set of 1,919
V genes analyzed included a total of 185,243 codons. Because
each codon consists of three nucleotide positions, and each
of these nucleotide positions can exchange to any one of
the three other nucleotides, there is a total possibility of
1,667,187 potential exchanges: (185,243) 
 
 
 
 (3 positions) 
 
 
 
(3 other bases) 
 
 
 
 1,667,187). In addition, each C was scored
for the frequency in context (within the V genes) that they
were preceded by a W (A or T) and then an R (A or G) and
thus were part of a hotspot for AID activity as previously de-
scribed (23, 27). Each C was also scored for how frequently it
occurred in a coldspot. Guanines were similarly scored for
occurrence in reverse-complement hotspots and coldspots.
For example, for FWR1 in Table S2 (available at http://
www.jem.org/cgi/content/full/jem.20042483/DC1), the 
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position two or “P2” of the TCC codon is listed as a coldspot
100% of the time. This means that every instance of TCC
that occurred in the FWR1 of all 1,919 V
 
H
 
 genes analyzed
was preceded by either a C or a G from position 3 of the pre-
vious codon such that the central C (TCC) was part of the
AID coldspot motif: “STC.” Fig. 3 graphically summarizes
the findings of Tables S2 through S6. To avoid confusion,
hereafter “predicted mutations” will refer to the sum of all
possible exchanges that could have occurred to the V genes
analyzed, whereas “actual mutations” will refer to the 28,307
mutations that actually did occur. As not all VH genes are
equally represented in the data set of 1,919 VH genes ana-
lyzed, there may be biases in the predicted frequency of mu-
tations reported. To generalize the findings for all VH genes,
one each of the 47 functional germline human VH genes
were pooled and analyzed for comparison. Thus “data set”
refers to the 1,667,187 exchanges that could have occurred to
the germline counterparts (unmutated) of the 1,919 VH
genes sequenced, and “all VH” refers to all possible ex-
changes that can occur in the 47 functional human VH genes.
Strikingly, within the CDRs, 67% (21,401/32,170) of
the Cs in the data set are in positions where mutations to
thymidine are silent, and 60% (12,929/21,401) of these
same Cs are associated with AID hotspots (Fig. 3 A, Silent
Figure 3. Codon bias plus AID hotspot and coldspot targeting. 
Predicted effect of C-to-T (A and B), G-to-A (C and D), or other exchanges 
(E and F) in the CDRs and FWRs occurring in the germline (unmutated) 
counterparts of the 1,919 IgVH genes analyzed herein referred to as data 
set (compiled from the data in Tables S2 through S6). “All VH” genes refers 
to the 47 functional human germline VH genes to demonstrate that 
although the “Data set” contained certain VH genes more frequently than 
others, it is representative of the mutation pattern predicted for all VH 
genes. “Silent” bars indicate predicted frequency of silent mutations, 
“Replacement” indicates predicted frequency of amino acid replacement 
mutations, and “Nonsense” represents mutations where the exchange 
would result in stop codons. Black portions of bars represent proportion of 
Cs or Gs found within AID hotspot motifs, gray portions represent propor-
tion of Cs or Gs in AID coldspots, and white represents Cs or Gs unaffected 
by either hotpots or coldspots (Neutral). White T bars represent the pro-
portion of replacements that would result only in conservative amino acid 
replacements. The dashed line in B represents the proportion of Cs occurring 
in silent hotspots that are near the CDRs or in the hypervariable portion of 
FWR3 described in the text. 
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bar). The frequency of C-to-T exchanges resulting in silent
mutations is significantly greater than the expected fre-
quency predicted by the genetic code or the frequency in
non-Ig genes (Fig. 1 C), and more than any other exchange
in the CDRs (Fig. 3, C and E; all comparisons by 
 
 
 
2
 
 with
P 
 
  
 
0.0001). Of the remaining Cs in the CDRs of the data
set that would produce replacement mutations when mu-
tated to thymidine (10,477), half (5,101) are associated with
AID coldspot motifs and thus are less likely to be mutated
(Fig. 3 A, gray portion of the Replacement bar). It is also
notable that although 700 of the 10,477 Cs that would
cause replacements if mutated to thymidine are found in
AID hotspot motifs (black portion of Replacement bar),
most (539/700 or 77%) of these would result only in alanine
to valine or hystidine to tyrosine exchanges and so are not
as likely to disrupt the structure of the Ig molecule. The
proportion of conservative replacement mutations are rep-
resented by white “Ts” within the black portion of the Re-
placement bar in Fig. 3. Thus, 99% (13,468/13,629) of all
CDR-localized AID hotspot motifs are associated with Cs
that if mutated to thymidine will result in silent or conser-
vative amino acid exchanges. Targeting of C deamination
to avoid amino acid replacements in the CDRs is evident
primarily for the coding strand in that the predicted fre-
quency of silent mutations due to the G-to-A transition
(noncoding strand C-to-T) is similar to that of other ex-
changes (Fig. 3 C, Data set, and Fig. 3 E). However, it is
notable that nearly half of the CDR replacements predicted
to occur following a G-to-A transition (9,032/19,057), in-
cluding 70% of those at AID hotspots (5,190/7,390), would
result only in conservative amino acid replacements (V-to-I,
S-to-N, and R-to-H; Fig. 3 C, Data set, white T bars). In
addition, approximately half (9,354/19,057) of the Gs are in
AID coldspots (Fig. 3, gray portion). Thus, G placement in
the CDRs appears to avoid nonconservative amino acid re-
placements as well. In conclusion, the most striking result of
this analysis is that the codons most commonly used to en-
code IgVH gene CDRs are highly biased such that most C
nucleotides occur in positions on either DNA strand where
if deaminated they either will not cause amino acid replace-
ments or the replacements will be preferentially conserva-
tive in nature.
The region that most intricately supports AID induction
of SHM without accumulation of amino acid replacements is
CDR1 in which 99% (5,682/5,731) of Cs are in positions
where mutation to thymidine will be silent or conservative,
and of these 90% (5,116/5,682) are associated with AID
hotspot motifs. Only 48 of 5,731, or 
 
 
 
1% of all CDR1 Cs
are in positions where AID deamination would cause a non-
conservative replacement mutation, and of these, 39 of 48
(81%) are within AID coldspots and thus are not likely to be
mutated. In conclusion, the Cs are intricately positioned in
the CDR1 so there are ample sites for AID-induced C
deamination to initiate the mutation process, but a mini-
mum of AID-mediated replacement mutations.
 
Codon usage in the FWRs biases for cytidine placement in 
silent positions that are predominantly coldspots for AID
 
Like the CDRs, codon use in the FWRs is biased in that Cs
are positioned so that transition to thymidine will result in a
minimum (only 35% or 43,429/124,401) of nonconservative
amino acid replacement (Fig. 3 B, Data set, Replacement,
except portions overlaid with white T- shaped bars rep-
resenting conservative replacements). Significantly, 84%
(36,518/43,429) of these “C-to-T replacement” Cs are
found in AID coldspot motifs (Fig. 3 B, Data set, Replace-
ment, gray portion of bar) that we speculate further protect
from the initiation of mutation in the FWRs. Thus Cs are
placed such that only 35% of C-to-T mutations will cause
amino acid replacements, which is significantly less frequently
than for all other exchanges in the FWRs, and less than if all
codons were used at a random frequency (56% for the genetic
code; Fig. 1 C, all comparisons by 
 
 
 
2
 
 with P 
 
  
 
0.0001).
Also similar to the CDRs most (55% or 68,691/124,401)
Cs in the FWRs would result in silent mutations or only
conservative amino acid replacements upon mutation to thy-
midine (Fig. 3 B, Data set, Silent bar and white T regions of
the replacement bar, 
 
 
 
2
 
, P 
 
  
 
0.05 compared with the pre-
dicted frequency of silent C-to-T mutations based on the
genetic code). Note that unlike the CDRs, 43% of the
“C-to-T silent” Cs are in AID coldspots (gray) and likely to
avoid induction of SHM by AID activity on the FWRs. The
31% of the FWR Cs at C-to-T silent positions found in AID
hotspots (black portion of Silent bar in Fig. 3 B, dashed bar)
are found in positions adjacent to the CDRs and thus would
prompt AID deamination of Cs targeting SHM to the
CDRs, or are within the hypervariable portion of FWR3
(42). Interestingly, the remaining 10% (12,281/124,401) of
Cs if mutated to thymidine would result in nonsense muta-
tions (Fig. 3 B, Nonsense bar), which is significantly greater
(
 
 
 
2
 
, P 
 
  
 
0.0001) than the 1% (212/33,114) of CDR Cs
leading to nonsense mutations (Fig. 3 A, Nonsense bar). It is
notable that 6% (3 of 48) of Cs in the genetic code would
result in nonsense mutations upon transition to thymidine,
accounting for some of this bias. In fact, the most frequently
occurring C in either FWR1 or FWR2 is associated with
the glutamine codon CAG that if mutated to TAG (C-to-T
exchange) forms a stop codon (Tables S2 and S6, available at
http://www.jem.org/cgi/content/full/jem.20042483/DC1).
Thus as discussed below, it appears that the FWRs may have
evolved such that loss of function is preferable to excessive
accumulation of replacements due to C-to-T exchanges fol-
lowing AID deamination.
The placement of G nucleotides in the FWRs is much
more biased than in the CDRs such that G-to-A mutations
were also predicted to be silent at a significantly greater fre-
quency (P 
 
  
 
0.0001) than other exchanges (besides C-to-T),
and thus replacement mutations due to noncoding strand
C deaminations are avoided. In addition, as with C nucle-
otides, most of the Gs in the FWRs are found in reverse
complement coldspot motifs (Fig. 4 D, gray portions of both 
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Figure 4. Targeting of SHM. (A) Like C and G nucleotides, A and T 
nucleotides are also positioned to target SHM to the CDRs (black) and 
out of the FWRs (white). Pol  tends to introduce point mutations at A 
in WA motifs during coding strand synthesis or at the reverse comple-
ment motifs (Ts in TW) during noncoding strand synthesis. Graph 
represents proportion of all As and Ts in WA or TW motifs from each 
region. The 17 non-Ig genes analyzed in Fig. 1 C were also analyzed for 
A and T positioning (gray). *, Significantly different by  2 test. (B) Anal-
ysis of silent mutation frequencies for Cs and Gs in AID hotpots, cold-
spots, and in neutral sequence contexts. The fold effect relative to 
neutral positions of hotspots and coldspots on mutation frequency is 
indicated at the base of the respective bars. (C and D) C-to-T and G-to-A 
mutation frequencies are remarkably predictable. There is no evidence 
for somatic selection of the CDR mutation frequencies and only mod-
erate selection for increased silent and conservative mutations to the 
FWRs. The predicted frequency of AID-induced C-to-T (C) or G-to-A 
(D) in the CDRs or FWRs is based solely on codon composition of the 
unmutated germline genes compared with the “Actual” accumulation 
of C-to-T or G-to-A mutations in the 28,307 mutations sequenced. 
“Predicted” represents all possible mutations to the 1,919 VH genes 
analyzed (the data set values of Fig. 3, A and B) adjusted for the in-
creased frequency of mutations at AID hotspots (3-fold for C-to-T and 
2.7-fold for G-to-A) or decreased frequency at coldspots (0.5- or 0.6-fold 
for C-to-T and G-to-A). 
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Silent and Replacement bars), which would reduce the fre-
quency of any mutations.
In conclusion, both C and G nucleotides appear to be
positioned in the FWRs to avoid the initiation of SHM and
to avoid replacements due to C deaminations on either
DNA strand. Thus, the well-characterized reduced mutation
frequency and preferential silent mutations in the FWRs are
due not just to selection against loss-of-function mutations as
previously believed, but also has evolved to utilize codons
that target AID activity by precise placement of Cs and Gs in
the V genes.
 
Prediction of mutations at cytidine and guanosine 
nucleotides for all VH genes is similar to 
the data set analyzed
 
As described above, the data set analyzed was not equally
representative of all VH genes. The observation that most Cs
and Gs are positioned to minimize the impact of C-to-T and
G-to-A mutations on the Ig protein, whereas targeting the
initiation of SHM to the CDRs and away from the FWRs is
quite similar for all VH genes as for the data set (Fig. 3, com-
pare Data set to All VH).
 
The AT phase of SHM is also targeted to the CDRs 
and out of the FWRs
 
As shown in Fig. 1 A and Fig. 2, there is a predominance of
A-to-G and T-to-C exchanges over other AT mutations. As
described above, pol
 
 
 
 is now known to be important for AT
mutations and is suspected to polymerize excised patches of
DNA following repair of AID-induced C deaminations
(9–13, 18). The most common error of Pol
 
 
 
 is to mispair Gs
rather than As with Ts, particularly if the preceding nucle-
otide is an A or T. This results in A-to-G mutations at WA
hotspots (underlined A is mutated) if the coding strand is
synthesized, and T-to-C mutations at TW hotspots if the
noncoding strand is synthesized. The intricate placement of
C and G nucleotides would seem to preclude targeted place-
ment of A and T nucleotides; however, this is not the case.
Surprisingly, within the CDRs, 54% and 51% of As and Ts,
respectively, are in WA or TW Pol
 
 
 
 hotspots, whereas only
20% of As and 23% of Ts are found in pol
 
 
 
 hotspots of the
FWRs (Fig. 4 A). For comparison, 36% of As are preceded
by A or T (WA) and 31% of Ts precede A or T (TW) in the
17 non-IgV genes analyzed above. In conclusion, in addition
to targeting AID-induced C and G mutations, the IgVH
genes have also evolved to target AT mutations to the CDRs
and to avoid AT mutations in the FWRs.
 
Hotspot/coldspot effects on mutation frequency
 
As described above, many C and G transitions likely arose
due to the direct activity of AID (29). Analysis of only silent
mutations provides relative mutation frequencies indepen-
dent of selective processes. Thus analysis of silent C-to-T
and G-to-A mutation frequencies should provide a direct as-
sessment of AID targeting to hotspot and coldspot motifs. As
indicated in Fig. 4 B, these silent mutations included 2,098
C-to-T mutations in 28,430 hotspots (frequency 
 
 
 
 74 mu-
tations occurred for each 1,000 silent C-to-T hotspots), 383
mutations at 32,405 coldspot Cs (12 mutations occurred for
each 1,000 silent C-to-T coldspots), and 596 mutations at
24,184 Cs that were neither hotspots nor coldspots (“neu-
tral”) giving a neutral frequency of 25 mutations per 1,000
C-to-T silent Cs. Thus, hotspot Cs were mutated to thymi-
dine at threefold the frequency of neutral Cs, and coldspots
were only mutated half as frequently. Similarly, silent G-to-A
mutations occurred at 67 per 1,000 reverse complement
hotspots (1,054/15,744), at 16 of 1,000 reverse complement
coldspots (537/34,068), and at 25 of 1,000 neutral positions
(303/12,022), or at a ratio of 2.7 to 1 mutations for hotspots
versus neutral and 0.6 to 1 for coldspots. The frequency of
hotspot and coldspot mutations corresponds well with previ-
ous in vivo and in vitro analyses (23, 32, 33).
 
The actual frequency and types of C-to-T and G-to-A 
mutations is highly predictable based solely on analysis 
of the VH gene sequences
 
The analyses above suggest that much of C and G transition
mutations are actually targeted by the IgVH gene sequences
themselves rather than selected for function during affinity
maturation. To determine the relative impact of V gene se-
quence versus selection during an immune repsonse, the fre-
quencies of C-to-T and G-to-A mutations predicted for the
various regions (Fig. 3, Data set graphs) was adjusted to factor
in the increased mutation frequency at hotspots (3-fold in-
crease for Cs and 2.7-fold increase for Gs) and decreased for
coldspots (0.5- and 0.6-fold decrease for Cs and Gs, respec-
tively). For the CDRs, the adjusted prediction of C-to-T and
G-to-A mutation spectrum was virtually identical to the ac-
tual frequencies observed (Fig. 4, C and D). The predicted
mutations for the FWRs were also quite similar to the actual
mutations, although some effect from selection was indicated
by the increased accumulation of silent mutations beyond
predicted (Fig. 4, C and D), and the preservation of critical
cytsteine residues in the FWRs (Table S1). In conclusion, as
C and G transitions represent the initiating step of SHM, this
analysis suggests that a good portion of mutational targeting
to the CDRs and out of FWRs may actually have resulted
due to evolutionary selection rather than somatic selection as
commonly thought.
 
DISCUSSION
 
The initiating phase I of SHM is believed to result from the
deamination of IgV gene Cs to deoxyuracil by AID that can
lead to accumulation of C-to-T and G-to-A transitions if not
repaired. Although targeting of SHM hotspots and coldspots
has been the topic of previous analyses (33, 37, 38, 43), the
selective pressures driving evolution of IgV gene sequences to
best support the activity of a mutation process initiated by C
deamination have not been previously considered. During
phase II of SHM the resulting dU/dG mismatches can be re- 
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paired by error-prone DNA repair processes leading to accu-
mulation of mutations of all nucleotides. Although these re-
pair processes are error-prone, their purpose is repair, and so
the fidelity of DNA synthesis cannot be too imprecise. Thus
in order to introduce mutations other than those introduced
from C deamination by AID (CG transitions), there must be
a great excess of C deaminations. For example, short-patch
excision repair in mammals involves excision and resynthesis
of 25–30 nucleotides of DNA around a mismatch, and the
polymerases involved such as Pol
 
 
 
 have an error rate of ap-
proximately one error per 500 nucleotides synthesized (18).
Thus assuming no further modulation of the repair processes,
for each deaminated C repaired, the chance that another er-
ror is introduced could be as low as only 5–6% (25/500 or
30/500). Thus as many as 20 C deaminations, most of which
would presumably be repaired, would be required for each
mutation introduced at A and T bases. With this in mind we
hypothesize that without placement of C and G nucleotides
to silent or conservative positions, there would be a bias in
the spectrum of amino acid replacements to involve codons
containing Cs and Gs. The result would be reduced diversity
that would limit the generation of high affinity antibodies,
causing a significantly increased length of time before a high
affinity B cell clone could be generated to mediate secondary
immune responses. Thus the observed targeting normalizes
CG replacement mutations to correspond with the occur-
rence of AT replacements, significantly increasing the effi-
ciency of affinity maturation.
Multiple factors appear to have simultaneously influenced
the intricate evolution of IgVH genes to support the
SHM process (summarized in Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20042483/DC1). Al-
though there was significant accumulation of C-to-T–induced
silent mutations, due to precise placement of Cs, replacements
due to C-to-T transitions were much less frequent than ex-
pected. Noncoding strand Cs were also clearly placed to avoid
G-to-A transitions leading to replacements in the FWRs, and
Gs are placed in the CDRs such that most G-to-A–induced
replacements involve only conservative amino acid exchanges
or are avoided completely by placement at coldspots. As the
role of AID in SHM as an RNA or DNA editor is still con-
troversial, it should be noted that other polymerases involved
(
 
 
 
 and 
 
 
 
) or other targeting mechanisms may preferentially in-
troduce transitions at CG base pairs, accounting for the target-
ing observed. The complexity of these evolved biases in
codon use are compounded by the precise concomitant
hotspot/coldspot targeting of both AID activity and the errors
typical of Pol
 
 
 
 to maximize the accumulation of mutations in
the CDRs and minimize mutations to the FWRs. Thus, be-
cause of evolved biases in codon usage to target AID activity,
the role of AID as an initiator of the SHM process is retained
although its role as a direct mutator is reduced. Thus the V
genes have evolved to normalize the replacement mutations
induced directly by AID to occur at a similar frequency to re-
placements from the repair phases of the SHM mechanism.
As indicated in Fig. 4, the distribution and pattern of C
and G transitions in the CDRs and FWRs is highly predict-
able based on analysis of the VH gene sequences alone.
Thus, as C and G transitions are indicators of the AID in-
duction of SHM, much of selection for functional mutagen-
esis to the CDRs and out of FWRs may have occurred dur-
ing evolution rather than somatically. The IgVH gene data
set includes the sum of 1,919 IgVH genes that were ran-
domly cloned and sequenced from the functional B cell rep-
ertoire, and thus certain IgVH genes are represented more
than others compared with the sum of 47 known functional
VH genes (Fig. 4, All VH). As indicated in Fig. 3, the data
set has both a modestly greater frequency of Cs placed in
hotspots if silent and placed in coldspots if they would cause
amino acid replacements, suggesting an even more dramatic
avoidance of replacements due to C-to-T in the practical
repertoire. This observation could be explained by somatic
selection for B cells that use IgV genes that most efficiently
support affinity maturation. However, it is well known that
particular VH genes are preferentially recombined (44) and
we and others have previously demonstrated that certain
genes including the biased proportion of those analyzed
herein are preferentially used in the B cell repertoire (39,
45). Thus the genes preferentially used for all B cells may be
the best substrates of mutation, possibly representing an even
greater complexity of evolutionary selection.
The most frequently used codon in the structurally im-
portant FWRs is CAG, which encodes glutamine. A C-to-T
exchange of this codon will result in the TAG amber stop
codon. Thus there may be an evolved bias to use codons that
would cause stop mutations upon C-to-T exchange in the
FWRs, suggesting a preference for loss-of-function rather
than loading of AID and initiation of the mutator. This com-
pares to the CDRs where initiation of SHM at Cs deami-
nated by AID without gross structural disruption is beneficial,
and codons may be used to avoid C-to-T induced stops.
There are only three codons in which C-to-T mutation will
result in nonsense mutation including the other glutamine
(Q) codon, CAA, and the arginine codon CGA. Structurally,
the most similar and often interchangeable amino acid to Q is
asparagine (N), however, C-to-T mutation of the N codons
do not result in stop codons. Interestingly, by the standard
CDR and FWR definitions, there are threefold more Qs
than Ns used in the FWRs and inversely, there is 1Q-to-3Ns
found in the CDRs of the 47 functional VH genes. If the hy-
pervariable amino acids in FW3 (Fig. 2, positions 76–85) are
counted as CDR4 as previously proposed (42), the observa-
tion is even more dramatic where there is a 7Q-to-1N ratio
in the FWRs and inversely a 1Q-to-4N ratio in the CDRs.
Similar analysis of the non-IgV genes described above dem-
onstrates that in most genes Qs and Ns occur at equal fre-
quencies. Thus nonsense mutations disrupting Ig translation
and presumably death of the B cell clone may be preferred to
induction of SHM in the FWRs. This adaptation may have
arisen to avoid production of structurally aberrant antibodies 
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that could result in immunoglobulin deposition disease. In-
versely, preferential use of N residues over Q residues in the
CDRs may have evolved to allow efficient induction of the
mutator without grossly disrupting Ig structure.
In conclusion, the IgV gene sequences appear to have
evolved to direct the induction of SHM by AID into the
CDR regions, but not the FWRs, while minimizing direct
amino acid replacements from the resulting C deaminations
in all regions. Juxtaposed on the targeting of AID is targeting
of AT mutations introduced by Pol
 
 
 
. The efficiency of affin-
ity maturation appears to be highly reliant on targeting of
SHM by the sequence of the V gene substrate. Thus, evolu-
tionary pressures have selected IgV genes to both maximize
and minimize SHM in critical regions of antibody molecules.
 
MATERIALS AND METHODS
 
Cloning and sequencing.
 
Total RNA from various B cell populations
sorted by flow cytometry were reverse transcribed and then subjected to
PCR using VH gene leader region specific sense primers and isotype spe-
cific antisense primers as previously described (3, 39, 46). All cDNA clones
were sequenced using automated DNA sequencers from Applied Biosys-
tems (ABI-377 or ABI 3730 DNA sequencers). We have previously re-
ported analyses of the frequency of nucleotide insertions and deletions (3),
receptor revision (46), and V gene selection (39) concerning many of these
sequences. All sequences were reanalyzed.
 
Analysis of IgVH genes for somatic mutations.
 
All IgVH gene se-
quence analyses were performed using software developed for this purpose
with the Microsoft Visual Basic and SQL query programming languages.
VH gene sequences were compared with the V gene sequence set from the
Immunogenetics database (41) using a stand-alone version of the NCBI
BLAST search engine (47). VH genes were analyzed through the FWR3
excluding the CDR3 as this region includes the variable/diversity/junc-
tional gene recombination junction, and thus it is not clear if mismatched
nucleotides resulted from somatic mutation or if they arose during diversify-
ing processes associated with VDJ recombination.
 
Statistical analyses.
 
All statistics were done using JMP version 5.01 (SAS
Institute Inc.) and Microsoft Excel.
 
Online supplemental materials.
 
Supplemental materials include a Mi-
crosoft Excel file listing all of the 28,307 mutations and reference sequences
(Table S1), the codons used by each variable gene region (Tables S2
through S6), and Fig. S1 and legend described in the discussion section.
Online supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20042483/DC1.
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